{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:35Z","timestamp":1788307235116,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.04.035","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T17:43:13Z","timestamp":1589305393000},"page":"4457-4463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Review of pediatric encephalitis and encephalopathy cases following immunization reported to the Canadian Immunization Monitoring Program Active (IMPACT) from 1992 to 2012"],"prefix":"10.1016","volume":"38","author":[{"given":"Jennifer","family":"Tam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2118-4174","authenticated-orcid":false,"given":"Julie A.","family":"Bettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sauv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taj","family":"Jadavji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Vaudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-368X","authenticated-orcid":false,"given":"Karina A.","family":"Top","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.035_b0005","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.inf.0000130075.56368.02","article-title":"Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993\u20132002","volume":"23","author":"Moore","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.04.035_b0010","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/01.inf.0000234067.84848.e1","article-title":"Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study","volume":"25","author":"Ray","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.04.035_b0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.vaccine.2011.10.104","article-title":"Lack of association between childhood immunizations and encephalitis in California, 1998\u20132008","volume":"30","author":"Pahud","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.035_b0020","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3201\/eid2109.150295","article-title":"Encephalitis Surveillance through the Emerging Infections Program, 1997\u20132010","volume":"21","author":"Bloch","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.035_b0025","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jpeds.2014.10.054","article-title":"Seizures, encephalopathy, and vaccines: experience in the National Vaccine Injury Compensation Program","volume":"166","author":"Lateef","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2020.04.035_b0030","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: Consensus statement of the International Encephalitis Consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.035_b0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1045-1870(03)00036-0","article-title":"Immunization monitoring program, active: a model of active surveillance of vaccine safety","volume":"14","author":"Scheifele","year":"2003","journal-title":"Seminars Pediatric Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.035_b0040","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/bmj.282.6276.1595","article-title":"Pertussis immunisation and serious acute neurological illnesses in children","volume":"282","author":"Miller","year":"1981","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2020.04.035_b0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1542\/peds.2006-3743","article-title":"Risk of serious neurologic disease after immunization of young children in Britain and Ireland","volume":"120","author":"Ward","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.04.035_b0050","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2013.08.087","article-title":"Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use","volume":"31","author":"Tozzi","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.035_b0055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.14745\/ccdr.v44i12a04","article-title":"Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017","volume":"44","author":"Johnson","year":"2018","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2020.04.035_b0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/archdischild-2015-308468","article-title":"Encephalitis in Australian children: contemporary trends in hospitalisation","volume":"101","author":"Britton","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2020.04.035_b0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1473-3099(17)30114-7","article-title":"30-year trends in admission rates for encephalitis in children in England and effect of improved diagnostics and measles-mumps-rubella vaccination: a population-based observational study","volume":"17","author":"Iro","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.035_b0070","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid2203.151545","article-title":"Encephalitis, Ontario, Canada, 2002\u20132013","volume":"22","author":"Parpia","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.035_b0075","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/ije\/dym207","article-title":"Review of the effect of measles vaccination on the epidemiology of SSPE","volume":"36","author":"Campbell","year":"2007","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2020.04.035_b0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.1933.02740280007003","article-title":"Vaccination against whooping cough","volume":"101","author":"Madsen","year":"1933","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2020.04.035_b0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/adc.49.1.46","article-title":"Neurological complications of pertussis inoculation","volume":"49","author":"Kulenkampff","year":"1974","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2020.04.035_b0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.282.6257.23","article-title":"Effect of a low pertussis vaccination uptake on a large community","volume":"282","year":"1981","journal-title":"British Med J"},{"key":"10.1016\/j.vaccine.2020.04.035_b0095","first-page":"1045","article-title":"Pertussis vaccine and encephalopathy after the Loveday trial","volume":"139","author":"Scheifele","year":"1988","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2020.04.035_b0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1474-4422(06)70446-X","article-title":"De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study","volume":"5","author":"Berkovic","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2020.04.035_b0105","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Sejvar","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:45:03Z","timestamp":1759401903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20305193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":21,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20305193"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of pediatric encephalitis and encephalopathy cases following immunization reported to the Canadian Immunization Monitoring Program Active (IMPACT) from 1992 to 2012","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}